preloader

M/S. S. G. PHARMACEUTICALS

F. NO. 8 (34)/2001/DP/NPPA-Div.II

GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY

NEW DELHI, DATED THE 10/05/2001

ORDER

In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/ revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;

TABLE

Sl. No. Name of the Formulation Pack Size Existing Retail Price (Rs.) Retail Price without Excise Duty Excise Duty (Rs.) Revised Retail Price with Excise Duty (Rs.)
1 Insunorm 5ml Liquid Injectable
Each ml contains
Chromatographed Insulin 40units/ml
0.3% metacresol as preservative
5ml Vial 64.50 0.00 64.50
2 Insunorm 10ml Liquid Injectable
Each ml contains
Chromatographed Insulin 40units/ml
0.3% metacresol as preservative
10ml Vial 121.34 0.00 121.34
3 Insulink-70/30 Liquid Injectable
Each ml contains
40IU Chromatographed insulin
(30% as soluble insulin & 70% as
Isophane Insulin); 0.16% M-Cresol;
0.065% Phenol IP as preservative
5ml Vial 64.59 0.00 64.59
4 Insulink-70/30 Liquid Injectable
Each ml contains
40IU Chromatographed insulin
(30% as soluble insulin & 70% as
Isophane Insulin); 0.16% M-Cresol;
0.065% Phenol IP as preservative
10ml Vial 121.52 0.00 121.52
5 Insulong NPH 5ml Liquid Injectable
Each ml contains
40IU Chromatographed Isophane insulin
0.16% M-Cresol; 0.065% Phenol as preservative
5ml Vial 64.60 0.00 64.60
6 Insulong NPH 10ml Liquid Injectable
Each ml contains
40IU Chromatographed Isophane insulin
0.16% M-Cresol; 0.065% Phenol as preservative
10ml Vial 121.54 0.00 121.54
7 Insulong-Z 5ml Liquid Injectable
Each ml contains
Chromatographed Insulin 40units/ml
(30% in amorphous state & 70% crystals)
0.08mg Zinc; 0.1% Methyl Paraben IP as preservative
5ml Vial 64.56 0.00 64.56
8 Insulong-Z 10ml Liquid Injectable
Each ml contains
Chromatographed Insulin 40units/ml
(30% in amorphous state & 70% crystals)
0.08mg Zinc; 0.1% Methyl Paraben IP as preservative
10ml Vial 121.46 0.00 121.46
9 Human Insunorm 5ml Liquid Injectable
Each ml contains
40IU Monocomponent Human Insulin
0.3% M-Cresol
5ml Vial 108.87 0.00 108.87
10 Human Insunorm 10ml Liquid Injectable
Each ml contains
40IU Monocomponent Human Insulin
0.3% M-Cresol
10ml Vial 210.08 0.00 210.08
11 Human Insulink-70/30 Liquid Injectable
Each ml contains
40IU Monocomponent Human Insulin
(30% as soluble insulin & 70% as
Isophane Insulin); 0.16% M-Cresol;
0.065% Phenol IP as preservative
5ml Vial 108.98 0.00 108.98
12 Insulink-70/30 Liquid Injectable
Each ml contains
40IU Monocomponent Human Insulin
(30% as soluble insulin & 70% as
Isophane Insulin); 0.16% M-Cresol;
0.065% Phenol IP as preservative
10ml Vial 210.30 0.00 210.30
13 Human Insulong NPH Liquid Injectable
Each ml contains
40IU Isophane insulin
(Monocomponent-Human)
0.16% M-Cresol; 0.065% Phenol as preservative
5ml Vial 108.99 0.00 108.99
14 Human Insulong NPH Liquid Injectable
Each ml contains
40IU Isophane insulin
(Monocomponent-Human)
0.16% M-Cresol; 0.065% Phenol as preservative
10ml Vial 210.32 0.00 210.32
15 Human Insulong-Z Liquid Injectable
Each ml contains
40units Monocomponent Human Insulin
(30% in amorphous state & 70% crystals)
0.08mg Zinc; 0.1% Methyl Paraben IP as preservative
5ml Vial 108.89 0.00 108.89
16 Human Insulong-Z Liquid Injectable
Each ml contains
40units Monocomponent Human Insulin
(30% in amorphous state & 70% crystals)
0.08mg Zinc; 0.1% Methyl Paraben IP as preservative
10ml Vial 210.12 0.00 210.12

2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of

  1. the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
  2. the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.

3. a. The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

  1. For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

4. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(S. K. BHATT)
Dy. Director

PN/45/2001/F
M/s S. G. Pharmaceuticals
Dr. Vikram Sarabhai Marg,
Wadi, Wadi,
Vadodara-390023

Last Page Updated: 31-05-2019